<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: The FDA&#8217;s big personalized-medicine push</title>
	<atom:link href="http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Mon, 23 Nov 2009 10:55:42 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Life sciences briefing: Thursday, Feb. 21, 2008 &#187; VentureBeat</title>
		<link>http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/comment-page-1/#comment-796066</link>
		<dc:creator>Life sciences briefing: Thursday, Feb. 21, 2008 &#187; VentureBeat</dc:creator>
		<pubDate>Thu, 21 Feb 2008 16:44:41 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/#comment-796066</guid>
		<description>[...] a result of genetic factors (see our coverage of this sort of &#8220;personalized medicine&#8221; here), such monitoring can help doctors avoid dangerous overdoses or to switch unresponsive patients to [...]</description>
		<content:encoded><![CDATA[<p>[...] a result of genetic factors (see our coverage of this sort of &#8220;personalized medicine&#8221; here), such monitoring can help doctors avoid dangerous overdoses or to switch unresponsive patients to [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Big Pharma&#8217;s personalized-medicine consortium: Is it for real?</title>
		<link>http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/comment-page-1/#comment-556460</link>
		<dc:creator>VentureBeat &#187; Big Pharma&#8217;s personalized-medicine consortium: Is it for real?</dc:creator>
		<pubDate>Fri, 28 Sep 2007 19:36:43 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/#comment-556460</guid>
		<description>[...] for short &#8212; has been a long, long time in coming, as I&#8217;ve noted here and here. Part of the reason, of course, is that personalizing medicine cuts against the economic interests [...]</description>
		<content:encoded><![CDATA[<p>[...] for short &#8212; has been a long, long time in coming, as I&#8217;ve noted here and here. Part of the reason, of course, is that personalizing medicine cuts against the economic interests [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Thursday, Sept. 13, 2007</title>
		<link>http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/comment-page-1/#comment-531848</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Thursday, Sept. 13, 2007</dc:creator>
		<pubDate>Thu, 13 Sep 2007 19:48:55 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/#comment-531848</guid>
		<description>[...] genomic tests to determine the proper dosing of warfarin, another blood thinner. (See our coverage here.)  For more stories on VentureBeat Life Sciences, click here.Tagged biotechnology, co:Aldagen, [...]</description>
		<content:encoded><![CDATA[<p>[...] genomic tests to determine the proper dosing of warfarin, another blood thinner. (See our coverage here.)  For more stories on VentureBeat Life Sciences, click here.Tagged biotechnology, co:Aldagen, [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Friday, Aug. 31, 2007</title>
		<link>http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/comment-page-1/#comment-502196</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Friday, Aug. 31, 2007</dc:creator>
		<pubDate>Fri, 31 Aug 2007 17:57:43 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/#comment-502196</guid>
		<description>[...] Aryx&#8217;s first candidate is a reengineered form of cisapride, an acid-reflux (read: heartburn) drug better known by the brand name Propulsid, which was withdrawn from the U.S. market after it was linked to heartbeat irregularities. Aryx is also at work on a redone version of warfarin, a blood thinner usually administered to people at risk of blood clots. (See our recent coverage of FDA&#8217;s decision to include pharmacogenomic information on the warfarin label that might alleviate side effects here.) [...]</description>
		<content:encoded><![CDATA[<p>[...] Aryx&#8217;s first candidate is a reengineered form of cisapride, an acid-reflux (read: heartburn) drug better known by the brand name Propulsid, which was withdrawn from the U.S. market after it was linked to heartbeat irregularities. Aryx is also at work on a redone version of warfarin, a blood thinner usually administered to people at risk of blood clots. (See our recent coverage of FDA&#8217;s decision to include pharmacogenomic information on the warfarin label that might alleviate side effects here.) [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Personalized Medicine: being up-to-date &#171; ScienceRoll</title>
		<link>http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/comment-page-1/#comment-494846</link>
		<dc:creator>Personalized Medicine: being up-to-date &#171; ScienceRoll</dc:creator>
		<pubDate>Fri, 24 Aug 2007 14:46:51 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/#comment-494846</guid>
		<description>[...] The FDA’s big personalized-medicine push (VentureBeat) [...]</description>
		<content:encoded><![CDATA[<p>[...] The FDA’s big personalized-medicine push (VentureBeat) [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Personalized medicine takes a (tiny) step forward</title>
		<link>http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/comment-page-1/#comment-450186</link>
		<dc:creator>VentureBeat &#187; Personalized medicine takes a (tiny) step forward</dc:creator>
		<pubDate>Thu, 16 Aug 2007 19:43:09 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/16/the-fdas-personalized-medicine-evangelism/#comment-450186</guid>
		<description>[...] REDUX: For more on the FDA&#8217;s big push behind personalized medicine, see this more recent post.  For more stories on VentureBeat Life Sciences, click here.Tagged AIDS, bucindolol, co:Arca [...]</description>
		<content:encoded><![CDATA[<p>[...] REDUX: For more on the FDA&#8217;s big push behind personalized medicine, see this more recent post.  For more stories on VentureBeat Life Sciences, click here.Tagged AIDS, bucindolol, co:Arca [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
